期刊文献+

反相高效液相色谱法测定原料药3-氯-3’,4’-二羟基二苯甲酮的含量及有关物质 被引量:1

Study on the determination of 3-chloro-3',4'-dihydroxy diphenylmethanone and its related substances by RP-HPLC
原文传递
导出
摘要 目的:建立反相高效液相色谱(RpHPLC)法测定原料药3-氯3’,4’-二羟基二苯甲酮(HP46)的含量及有关物质。方法:采用Diamonsil C1-(250mm×4.6mm,5μm)色谱柱,以甲醇-乙腈-水(用磷酸调节pH至3.0)(65:5:30)为流动相,流速0.8mL·min,检测波长243nm,柱温25℃,外标法测定HP46含量,自身对照法测定有关物质。结果:有关物质与主药分离良好,主药含量高于99%,HP46在3.0-180mg·L-1范围内线性关系良好(r=0.9999),最低检测限1mg·L-1。结论:建立的高效液相色谱方法灵敏性和专属性好,适用于原料药HP46的质量控制、有关物质检测和稳定性检查。 OBJECTIVE To establish a RP-HPLC method for the determination of 3-chloro-3' ,4'-dihydroxy diphenylmethanone (HP46) and its related substances. METHODS HPLC method was carried on a column of Diamonsil C18 (250 mm×4. 6 mm,5μm) with the mobile phase of methanol acetonitrile-water(adjusted the pH value to 3.0 with phosphoric acid)(65:5:30) at the flow rate of 0. 8 mL.min-1 and the detection wavelength was set at 243 nm. The column temperature was 25℃. HP46 was quantified with external standard method. The related substances were determined by the self-control method. RESULTS Related substances and degraded substances were completely separated from HP46. The content of HP46 was above 99%. The calibration curve of HP46 was linear in range from 3.0 to 180 mg.L-1 (r= 0. 9999). The minimal detection limit was 1 mg·L-1. CONCLUSION The HPLC method has been developed for quality control, detection of related substances and stability study of HP46 with high sensitivity and specificity.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第3期185-187,共3页 Chinese Journal of Hospital Pharmacy
基金 国家高技术研究发展计划(863计划)项目(编号:2006AA09Z446) 山西省回国留学人员科研项目(编号:2008-51) 山西省高等学校科技项目(编号:200811011)
关键词 3-氯-3’ 4’-二羟基二苯甲酮 高效液相色谱 含量测定 有关物质 3-chloro-3' ,4'-dihydroxy diphenylmethanone HPLC determination related substances
  • 相关文献

参考文献5

二级参考文献33

  • 1王宏运,王绍欣,李转珍,牟建军.肥胖高血压病患者血清FFA和ET-1检测及临床分析[J].中国心血管病研究,2005,3(1):56-57. 被引量:4
  • 2段留法,郑秋甫,张丽萍,曾强,范英鲜,唐朝枢.自发性高血压大鼠血管内皮功能不全发生机理实验研究[J].中国康复理论与实践,2005,11(6):413-414. 被引量:7
  • 3郭西民,李现东.雷米普利对老年高血压病患者脉压的影响[J].山东医药,2006,46(17):84-84. 被引量:1
  • 4陈修,陈维洲,曾贵云.心血管药理学[M].4版,北京:人民卫生出版社,2006:746-748.
  • 5王秀兰,李虹伟,张淑文主译.临床药物治疗学[M].8版.北京:人民卫生出版社,2007:16-18.
  • 6Loomans CJ,De Koning EJ,Staal FJ,et al.Endothelial progenitor cell dysfunction in type 1 diabetes:another consequence of oxidative stress?[J].Antioxid Redox Signal,2005,7(11~12):1468
  • 7Reinhart K,Bayer O,Brunkhorst F,et al.Markers of endothelial damage in organ dysfunction and sepsis[J].Crit Care Med,2002,30(5):302
  • 8Goon PK,Lip GY,Boos CJ,et al.Circulating endothelial cells,endothelial progenitor cells,and endothelial microparticles in cancer[J].Neoplasia,2006,8(2):79
  • 9Shyy JY,Chien S.Role of integrins in endothelial mechanosensing of shear stress[J].Circ Res,2002,91(9):769
  • 10Schmieder RE.Endothelial dysfunction:how can one intervene at the beginning of the cardiovascular continuum?[J].J Hypertens Suppl,2006,24(2):31

共引文献125

同被引文献4

  • 1崔福德.药剂学[M] .7版.北京:人民卫生出版社,2011:197-198.
  • 2Zhao WY, Feng XE, Ban SR,et al. Synthesis and biological activity of halophenols as potent antioxidant and cytoprotective agents [ J ]. Bioorg Med Chem Lett,2010,20(14) :4132 -4134.
  • 3Okonogi S, Puttipipatkhachom S. Dissolution improvement of high drug-loaded solid dispersion [ J ]. Aaps Pharm Sci Tech, 2006,7 (2) :E148 - E153.
  • 4陈周全,张宁.固体分散体技术在中药制剂中的应用概况[J].中国药房,2012,23(15):1427-1429. 被引量:17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部